AP, R., DJ, C., G, M., A, S., M, V., DA, S., . . . KS, A. (2024). Prodrug nanotherapy demonstrates in vivo anticryptosporidial efficacy in a mouse model of chronic Cryptosporidium infection. RSC pharmaceutics, 1(5), 963. https://doi.org/10.1039/d4pm00093e
Chicago Style (17th ed.) CitationAP, Ranjan, et al. "Prodrug Nanotherapy Demonstrates in Vivo Anticryptosporidial Efficacy in a Mouse Model of Chronic Cryptosporidium Infection." RSC Pharmaceutics 1, no. 5 (2024): 963. https://doi.org/10.1039/d4pm00093e.
MLA (9th ed.) CitationAP, Ranjan, et al. "Prodrug Nanotherapy Demonstrates in Vivo Anticryptosporidial Efficacy in a Mouse Model of Chronic Cryptosporidium Infection." RSC Pharmaceutics, vol. 1, no. 5, 2024, p. 963, https://doi.org/10.1039/d4pm00093e.